University of Texas-Health Science Center, Houston, USA.
Am J Cardiol. 2012 Jan 15;109(2):238-40. doi: 10.1016/j.amjcard.2011.08.036. Epub 2011 Oct 12.
Poor patients in developing countries may not receive permanent pacemakers (PPMs) even as lifesaving measures because of their high cost. In this report we examined whether PPMs that were explanted and donated by funeral homes in the United States could be safely and effectively reused in indigent patients in India. With permission from the deceased patients' families, 121 PPMs were explanted and donated by funeral homes for reuse. These PPMs were sterilized and sent for implantation in needy and indigent patients at a charity hospital in Mumbai, India. From the pool of donated 121 PPMs, 53 (88%, 11 single-chamber PPMs, 21%, and 42 dual-chamber PPMs, 79%) were acceptable for reuse and implanted (37 new implants, 70%, and 16 for battery/generator replacement, 30%) in 53 patients (mean ± SD 64 ± 10 years old, 28 women, 53%). Indications for PPM implantation were complete heart block (n = 27, 51%) and sick sinus syndrome (n = 26, 49%). All patients were alive and well postoperatively. No significant complications including infections or device failures occurred over 19 to 1,827 days (mean 661) of follow-up. Of 40 patients (75%) who were followed locally, 4 (10%) died because of nonpacemaker-related causes; time to death was 121 to 750 days (mean 430) after PPM implantation. All except 2 patients (5%) reported marked improvement in their symptoms. There were only 4 patients (8%) who were previously employed, and all were able to resume their manual labor work. Also, of the women, 27 patients (96%) reported improvement in symptoms enabling them to resume regular household chores as housewives after PPM implantation. In conclusion, with proper device sterilization and handling protocols, reuse of explanted PPMs in poor patients in developing countries is safe and effective. Implantation of donated PPMs can not only save lives but also improve quality of life of needy poor patients.
发展中国家的贫困患者可能因起搏器价格昂贵而无法接受这种救生措施。在本报告中,我们研究了美国殡仪馆捐献并重新使用的起搏器是否可以安全有效地用于印度的贫困患者。在征得已故患者家属同意后,殡仪馆共捐献了 121 个起搏器,以供重新使用。这些起搏器经过消毒,送往印度孟买一家慈善医院,供有需要的贫困患者植入。在 121 个捐献的起搏器中,有 53 个(88%,其中单腔起搏器 11 个,占 21%,双腔起搏器 42 个,占 79%)符合重新使用标准并植入患者体内(37 个为新植入,占 70%,16 个为电池/发电机更换,占 30%),共 53 名患者(平均年龄 64 ± 10 岁,女性 28 名)。植入起搏器的指征为完全性心脏阻滞(27 例,51%)和病态窦房结综合征(26 例,49%)。所有患者术后均存活且状况良好。在 19 至 1827 天(平均 661 天)的随访期间,没有出现包括感染或器械故障在内的严重并发症。在接受当地随访的 40 名患者(75%)中,有 4 人(10%)因与起搏器无关的原因死亡;死亡时间为起搏器植入后 121 至 750 天(平均 430 天)。除 2 名患者(5%)外,所有患者均报告症状明显改善。只有 4 名患者(8%)之前有工作,所有人都能够恢复体力劳动。此外,27 名女性患者(96%)报告症状改善,使她们能够在植入起搏器后恢复家庭主妇的日常家务劳动。总之,通过适当的设备消毒和处理程序,重新使用发展中国家贫困患者的起搏器是安全有效的。植入捐献的起搏器不仅可以拯救生命,还可以改善贫困患者的生活质量。